Amiodarone Hydrochloride is a class III antiarrhythmic with a uniquely broad multi-channel mechanism, blocking potassium, sodium and calcium currents alongside beta-adrenergic effects, making it effective against a wide range of ventricular and atrial arrhythmias. Simson Pharma's Amiodarone Hydrochloride reference standard and impurities support the demanding stability-indicating testing required of this complex, iodine-containing antiarrhythmic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Amiodarone Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.